MEET THE TEAM
Simon Kerry PhD MBA
Simon is an experienced life-science entrepreneur with over 25 years in senior leadership roles at European biotechnology companies. He has been an Operating Partner at Advent since 2017. Before Advent, he was CEO of Karus Therapeutics, where he took the company from spin-out to clinical development, raising significant investment from leading European and US VCs.
Prior to Karus, Simon led the Business Development team at Ablynx, securing key partnering agreements during a critical stage of the company’s development. Before Ablynx, Simon was responsible for Business Development within the Active Biotech group of companies and was founding director of Active Biotech spin-out Isogenica Ltd. Following a first degree in Medicinal Chemistry, Simon started his career as a chemist at GD Searle (UK). He completed his PhD in 1989 and obtained an Executive MBA from Loughborough University Business School in 1995.